Clinical, virologic, and immunologic response to efavirenz- or protease inhibitor-based highly active antiretroviral therapy in a cohort of antiretroviral-naive patients with advanced HIV infection (EfaVIP 2 study)

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Number of pages1
JournalInfectious Diseases in Clinical Practice
Volume12
Issue number4
DOIs
StatePublished - Jan 1 2004

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this